David J Grelotti
Overview
Explore the profile of David J Grelotti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
865
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Almeida A, Conway M, Grelotti D, Gupta A, Frank D, Borquez A
Addiction
. 2025 Mar;
PMID: 40079161
Background And Aims: Better understanding the challenges faced by patients on medications for opioid use disorder (MOUD), including methadone and buprenorphine, is critical to increasing their use/retention. Social media platforms...
2.
Brady V, Willig A, Christopoulos K, Grelotti D, Yendewa G, OCleirigh C, et al.
AIDS Behav
. 2025 Feb;
PMID: 39961951
Type 2 diabetes (T2DM) and depressive symptoms frequently co-occur among people with HIV (PWH). Depression may impact diabetes management in PWH. This study evaluated the prevalence of concurrent T2DM and...
3.
Grelotti D, Montoya J, Delorme-Walker V, Iudicello J, Ellis R, Grant I, et al.
Nat Ment Health
. 2024 Aug;
2(8):879-880.
PMID: 39211438
People with HIV and comorbid substance use problems may be among those who benefit most from long-acting HIV antiretroviral treatment, but they are routinely excluded from Phase 3 clinical trials....
4.
Laird A, Le A, Kulbe J, Umlauf A, Sagarian M, Spencer M, et al.
NeuroImmune Pharm Ther
. 2024 Aug;
3(2):113-128.
PMID: 39175522
Objectives: People with HIV (PWH) have high rates of depression and neurocognitive impairment (NCI) despite viral suppression on antiretroviral therapy (ART). Mounting evidence suggests that immunometabolic disruptions may contribute to...
5.
Marcotte T, Umlauf A, Grelotti D, Sones E, Mastropietro K, Suhandynata R, et al.
JAMA Psychiatry
. 2023 Aug;
80(9):914-923.
PMID: 37531115
Importance: With increasing medicinal and recreational cannabis legalization, there is a public health need for effective and unbiased evaluations for determining whether a driver is impaired due to Δ9-tetrahydrocannabinol (THC)...
6.
Fitzgerald R, Umlauf A, Hubbard J, Hoffman M, Sobolesky P, Ellis S, et al.
Clin Chem
. 2023 May;
69(7):724-733.
PMID: 37228223
Background: Cannabis is increasingly used both medically and recreationally. With widespread use, there is growing concern about how to identify cannabis-impaired drivers. Methods: A placebo-controlled randomized double-blinded protocol was conducted...
7.
Cachay E, Moges T, Qin H, Bamford L, Grelotti D, Mathews W
Addict Behav Rep
. 2023 Mar;
17:100486.
PMID: 36950716
Objectives: People living with HIV (PWH) with substance or alcohol use often have unsuppressed plasma HIV viral loads (pVL). The degree to which substance and alcohol use effects on HIV...
8.
Hannawi A, Knight C, Grelotti D, Trauner D
Adv Neurodev Disord
. 2022 May;
6(2):206-210.
PMID: 35541570
Objectives: The COVID-19 pandemic and the resulting social changes have made unprecedented changes in our lifetime with unknown repercussions on children with autism spectrum disorders. We sought to assess the...
9.
Marcotte T, Umlauf A, Grelotti D, Sones E, Sobolesky P, Smith B, et al.
JAMA Psychiatry
. 2022 Jan;
79(3):201-209.
PMID: 35080588
Importance: Expanding cannabis medicalization and legalization increases the urgency to understand the factors associated with acute driving impairment. Objective: To determine, in a large sample of regular cannabis users, the...
10.
Swinton M, Sundermann E, Pedersen L, Nguyen J, Grelotti D, Taffe M, et al.
Viruses
. 2021 Sep;
13(9).
PMID: 34578323
HIV-associated neurocognitive disorders (HAND) persist despite the advent of antiretroviral therapy (ART), suggesting underlying systemic and central nervous system (CNS) inflammatory mechanisms. The endogenous cannabinoid receptors 1 and 2 (CB...